apixaban

The priority review not only clears the way for an earlier-than-expected launch of Eliquis, whose active ingredient is called apixaban, but it is also a potential signal that the FDA views it as superior to other new anticlotting drugs, including Pradaxa from Boehringer Ingelheim GmbH and Xarelto from Johnson & Johnson and Bayer AG.

Stroke Drug to Get Speedy FDA Review Peter Loftus 2011

Researchers said Sunday that the drug, called apixaban, reduced the risk of stroke in patients with a heartbeat irregularity called atrial fibrillation by 21% and lowered by 31% the incidence of bleeding, a serious side effect of warfarin.

Study Gives Lift to Drug That Cuts Stroke Risk Ron Winslow 2011

The trial tested the drug, also known as apixaban, against standard stroke-prevention treatment warfarin in a pool of patients with atrial fibrillation as well as at least one additional risk factor for stroke.

Rival Drug Success Pressures Bayer Sten Stovall 2011

Other contenders in the market include Bristol-Myers Squibb Co., which is developing a pill called apixaban with Pfizer Inc.

Race Is on for the Next Blood Thinner 2007

At the press conference for the ARISTOTLE trial at the ESC the investigators noted that the pharmacology of apixaban, which is given twice-daily, is not substantially different from that of rivaroxaban.

unknown title 2011

CBS Warfarin may be the usual drug for preventing strokes in people with the heart rhythm problem known as atrial fibrillation, but a new study shows that an experimental blood thinner called apixaban works way better.

Breaking News: CBS News 2011

BMY have teamed up to create a blood-thinning drug called apixaban, and results from the drug that were just released showed that it outperformed the widely used drug warfarin in stroke-prevention.

unknown title 2011

Eliquis, also called apixaban, showed superiority over warfarin in effectiveness, safety and saving lives in a clinical trial presented last month at a scientific meeting in Paris, affirming its place as the potential leader of the pack.

Reuters: Press Release 2011

BMY have teamed up to create a blood-thinning drug called apixaban, and results from the drug that were just released showed that it outperformed the widely used drug warfarin in stroke-prevention.

unknown title 2011

The approval by the European commission means the drug, known as apixaban, will be available in the 27 countries of the European Union.

The Seattle Times 2011